BridgeMD
Compares treatment options for Atrophic Acne Scars
Official title Subcision With Injection of Poly Deoxyribonucleotide Versus Subcision With Injection of Non-cross Linked Hyaluronic Acid in Rolling Acne Scars Treatment.
ClinicalTrials.gov ID: NCT07547956
What this study is testing
- What it's testing
- The aim of this study is to evaluate and compare the efficacy and safety of two different injectable agents combined with subcision for treating rolling acne scars. In this split-face clinical trial, each participant will receive subcision on both sides of the face.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Moderate to severe mainly rolling acne scars per validated scale (Goodman \& Baron Grade 3-4)
- Scars must be bilaterally distributed, allowing for split-face comparison
- Stable acne (no active nodulocystic lesions, pustules, or recent outbreaks for ≥6 months)
- No scar treatments (e.g., fillers, laser, microneedling) within the past 12 months
- All skin types.
You likely can't join if
- Systemic retinoid treatment within the last 6 months
- Active inflammatory acne
- Lidocaine sensitivity
- Pregnancy and lactation
- Severe systemic illness or malignancy
- Use of anticoagulant or antiplatelet medications (unless cleared) Use of oral isotretinoin within the past 6 month
See the full eligibility criteria
- Moderate to severe mainly rolling acne scars per validated scale (Goodman \& Baron Grade 3-4)
- Scars must be bilaterally distributed, allowing for split-face comparison
- Stable acne (no active nodulocystic lesions, pustules, or recent outbreaks for ≥6 months)
- No scar treatments (e.g., fillers, laser, microneedling) within the past 12 months
- All skin types.
- Both genders above 18 years old
- Systemic retinoid treatment within the last 6 months
- Active inflammatory acne
- Lidocaine sensitivity
- Pregnancy and lactation
- Severe systemic illness or malignancy
- Use of anticoagulant or antiplatelet medications (unless cleared) Use of oral isotretinoin within the past 6 month
- Herpes libialis, bacterial infection, other infections such as HBV, HCV or HIV
- Tendency to keloid formation
- Allergy to fish and salmon
The study team makes the final eligibility decision.
Where it's taking place
- Cairo, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Cairo, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.